Position in RPRX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,205,250
+$531,823 QoQ
Shares Held
75,000
-21.1% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#219
of 639 holders
Holding Since
Mar 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Derivatives in RPRX
reported options exposure · as of Sep 30, 2025CallValue
$264,600
CallShares
7,500
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Verition Fund Management LLC holds $152,220,097 across 64 Biotechnology names. RPRX ranks #8 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TECH |
BIO-TECHNE Corp
|
438,746 | $30,997,404 | |
| 2 | APGE |
Apogee Therapeutics, Inc.
|
159,256 | $21,138,048 | |
| 3 | ABVX |
Abivax S.A.
|
105,791 | $14,097,708 | |
| 4 | IDYA |
IDEAYA Biosciences, Inc.
|
184,054 | $6,859,692 | |
| 5 | SNDX |
Syndax Pharmaceuticals Inc
|
304,939 | $6,665,966 | |
| 6 | MRVI |
Maravai Lifesciences Holdings, Inc.
|
777,738 | $4,853,085 | |
| 7 | CYTK |
Cytokinetics Inc
|
54,889 | $4,675,993 | |
| 8 | RPRX |
Royalty Pharma plc
This page
|
75,000 | $4,205,250 |
All Filings in RPRX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,205,250 | 75,000 | Shares | Sole | 2026-08-14 | |
| 2025-12-31 | $3,673,427 | 95,068 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $264,600 | 7,500 | Call | Sole | 2025-11-14 | |
| 2025-09-30 | $10,621,679 | 301,068 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $4,812,743 | 133,576 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $4,212,418 | 135,317 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $2,526,484 | 99,039 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $788,414 | 27,869 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $526,081 | 19,950 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $649,340 | 21,381 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $840,284 | 29,914 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $895,348 | 32,990 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,288,159 | 41,905 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $662,375 | 18,384 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,271,832 | 32,182 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,371,263 | 34,128 | Shares | Sole | 2023-01-18 | |
| 2022-06-30 | $374,702 | 8,913 | Shares | Sole | 2022-08-30 | |
| 2022-03-31 | $1,808,250 | 46,413 | Shares | Sole | 2022-06-02 | |
| 2021-09-30 | $733,605 | 20,299 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,352,670 | 33,000 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $255,351 | 5,854 | Shares | Sole | 2021-05-18 | |
| No filing history on record for this holder in this stock. | ||||||